Triple analysis report in oncology : Market Research Report

You're currently on:

Home
/
Publication Series
/
Analytical Tool
/
Triple Analysis

My Cart

You have no items in your shopping cart.

Market Research:

Biotechnology
- Bioinformatics
- Companies
- Genomics
- Markets
- Proteomics
- Technologies
Business Development
- Branding
- Licensing
Chemicals
Country
- Argentina
- Australia
- Austria
- Bahrain
- Bangladesh
- Belarus
- Belgium
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Costa Rica
- Croatia
- Cuba
- Czech Republic
- Denmark
- Egypt
- Estonia
- Europe
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Iran
- Ireland
- Israel
- Italy
- Japan
- Jordan
- Kuwait
- Latvia
- Lithuania
- Malaysia
- Malta
- Mexico
- Morocco
- Netherlands
- New Zealand
- North America
- Norway
- Oman
- Pakistan
- Peru
- Phillippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Syria
- Taiwan
- Thailand
- Turkey
- Ukraine
- United Arab Emirates
- United Kingdom
- USA
- Venezuela
- Vietnam
Diagnostics
- Diagnostic Imaging
- Diseases
  - Cardiovascular
- Glucose Testing
- Home Testing
- In Vitro Diagnostics
- In Vivo Diagnostics
- In-Office Testing
- Laboratory Testing
- Markets
- Point-of-Care Diagnostics
Drug Delivery
- Companies
Drug Discovery
Drugs
Finance & Investment
Generic Drugs
- Biogenerics
- Companies
- Markets
Healthcare
- Hospital
- OTC
IT & eHealth
- Markets
Management
Marketing & Sales
- Branding
- Markets
- Pharmacoeconomics
Medical Devices
- Companies
- Markets
Production
Publication Series
- Analytical Tool
- Commercial and Pipeline Insight
- Commercial Insight
- Deals & Alliances Reports
- Detailed Product Pipeline Reports
- Financial Company Reports
- Financial Markets Research
- Pharma Partnering Guides
- PharmaVitae
- Pipeline and Commercial Insight
- Pipeline Insight
- Pipeline Perspectives
- Premium Company Profile
- Private Company Reports
- Spotlight Reports
- Stakeholder Insight
- Stakeholder Opinions
- Therapeutic Competitor Reports
- Therapy Area Pipeline Reports
R&D
Regulation & Policy
- Intellectual Property
- Pricing & Reimbursement
Therapeutics
- Companies
- Diseases & Conditions
- Line of Treatment
- Markets
Veterinary

Triple Analysis

Triple analysis report is a constellation of three independent Cancer Focus Areas to act as a decision support tool to business development and pipeline portfolio management in oncology. It uses standardized criteria in a five pillar pipeline drug assessment to compare drug development strategies in cancer, which makes it easy to find and compare analysis not only within one single Cancer Focus Area but also between different areas.

Find the Triple Analysis Report in oncology which best suits your needs by selecting any three (3) out of these 14 high impact Cancer Focus Areas.

Sort by

Set Ascending Direction

Triple Analysis: Colorectal Cancer, Melanoma and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Colorectal Cancer, Prostate Cancer and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Colorectal Cancer, Apoptosis and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

Triple Analysis: Colorectal Cancer, Angiogenesis and Cancer Vaccines

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More

Triple Analysis: Colorectal Cancer, Angiogenesis and Protein Kinase Inhibitors

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More

Triple Analysis: Colorectal Cancer, Angiogenesis and Antibodies

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Antibodies). Learn More

Triple Analysis: Colorectal Cancer, Angiogenesis and Peptides

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More

Triple Analysis: Leukemia, Lung Cancer and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Leukemia, Lymphoma and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Leukemia, Melanoma and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Leukemia, Pancreatic Cancer and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Leukemia and Pancreatic Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Leukemia, Prostate Cancer and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in both Leukemia and Prostate Cancer and by the mechanism/target/effect of Angiogenesis. Learn More

Triple Analysis: Leukemia, Apoptosis and Angiogenesis

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More

Triple Analysis: Leukemia, Angiogenesis and Cancer Vaccines

Published by BioSeeker Group on Sep 7th, 2010

€ 3,450.00

This triple analysis focuses on cancer drug development strategies in Leukemia and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Learn More

Sort by

Set Ascending Direction